Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-08-15

Clinical Trial Update: Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of EIB [NA]

View source ↗

Summary

A clinical trial evaluating the AlphaCore non-invasive vagus nerve stimulation device for relief of asthma-related symptoms was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AlphaCore Device

Snippet

Sponsor: ElectroCore INC | Conditions: Asthma | NA | Status: WITHDRAWN